Đang chuẩn bị liên kết để tải về tài liệu:
Targeted genome editing in acute lymphoblastic leukemia: A review

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Genome editing technologies offers new opportunities for tackling diseases such as acute lymphoblastic leukemia (ALL) that have been beyond the reach of previous therapies. | Targeted genome editing in acute lymphoblastic leukemia: A review

TÀI LIỆU LIÊN QUAN

Induction of targeted, heritable mutations in barley and Brassica oleracea using RNA-guided Cas9 nuclease

CRISPR-Cas9 mediated targeted disruption of FAD2–2 microsomal omega-6 desaturase in soybean (Glycine max.L)

Characterization of background noise in capture-based targeted sequencing data

Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort

BART-Seq: Cost-effective massively parallelized targeted sequencing for genomics, transcriptomics, and single-cell analysis

Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis

Revolutionary genome editing tools for crop improvement

STRScan: Targeted profiling of short tandem repeats in whole-genome sequencing data

Flexible and efficient genome tiling design with penalized uniqueness score

Successful generation of epigenetic disease model mice by targeted demethylation of the epigenome
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.